DAM
BIO icon

Delta Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Delta Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-8
Closed -$2K – 687
2017
Q3 		$2K Buy
+8
New +$1.8K ﹤0.01% 556
2017
Q2 		– Sell
-32
Closed -$6K – 595
2017
Q1 		$6K Hold
32
– – ﹤0.01% 483
2016
Q4 		$6K Hold
32
– – ﹤0.01% 473
2016
Q3 		$5K Hold
32
– – ﹤0.01% 488
2016
Q2 		$5K Hold
32
– – ﹤0.01% 480
2016
Q1 		$4K Hold
32
– – ﹤0.01% 490
2015
Q4 		$4K Hold
32
– – ﹤0.01% 500
2015
Q3 		$4K Buy
+32
New +$4.61K ﹤0.01% 492

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HCM
Hitchwood Capital Management New York $184M AUM 3.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Delta Asset Management's BIO Position: Q4 2017 in Review

Delta Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2017, closing a stake of 8 shares — an estimated $2K sold.

Delta Asset Management first reported a position in BIO in Q3 2015 and held it in 8 quarters. The position peaked at $6K in Q1 2017. 302 funds tracked by Wall St. Rank hold BIO as of Q4 2017.

  • Delta Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2017 after selling out during the quarter.
  • Delta Asset Management sold 8 Bio-Rad Laboratories Class A shares in Q4 2017, an estimated $2K.
  • Delta Asset Management first reported a position in Bio-Rad Laboratories Class A in Q3 2015 and held it in 8 quarters.
  • Delta Asset Management's Bio-Rad Laboratories Class A position peaked at $6K in Q1 2017.
  • 302 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2017.

Based on Delta Asset Management's 13F filing for Q4 2017, filed 23 Jan 2018.